StonvexLoading…
StonvexStonvexStonvexCore line items from ERIE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.01B | $4.07B | $3.12B | $2.05B |
Operating Income | $166.79M | $717.18M | $559.47M | $350.55M |
Net Income | $150.47M | $559.34M | $495.95M | $174.69M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $3.38B | $3.36B | $3.32B | $3.13B |
Total Liabilities | $1.02B | $1.07B | $1.02B | $943.67M |
Cash & Equivalents | $268.62M | $345.87M | $568.55M | $358.03M |
Free Cash Flow OCF − CapEx | $54.48M | $570.97M | $430.18M | $245.76M |
Shares Outstanding | Not available | Not available | Not available | Not available |